135 related articles for article (PubMed ID: 26278643)
81. Microbial Regulation of p53 Tumor Suppressor.
Zaika AI; Wei J; Noto JM; Peek RM
PLoS Pathog; 2015 Sep; 11(9):e1005099. PubMed ID: 26379246
[TBL] [Abstract][Full Text] [Related]
82. Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype.
Ibragimova MK; Tsyganov MM; Litviakov NV
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771512
[TBL] [Abstract][Full Text] [Related]
83. Mathematical Modelling of p53 Signalling during DNA Damage Response: A Survey.
Eliaš J; Macnamara CK
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638930
[TBL] [Abstract][Full Text] [Related]
84. Two-dimensional polynomial type canonical relaxation oscillator model for p53 dynamics.
Demirkıran G; Kalaycı Demir G; Güzeliş C
IET Syst Biol; 2018 Aug; 12(4):138-147. PubMed ID: 33451182
[TBL] [Abstract][Full Text] [Related]
85. Sliding mode controller-observer pair for p53 pathway.
Rizwan Azam M; Utkin VI; Arshad Uppal A; Bhatti AI
IET Syst Biol; 2019 Aug; 13(4):204-211. PubMed ID: 31318338
[TBL] [Abstract][Full Text] [Related]
86. Programmed cell death: the battlefield between the host and alpha-herpesviruses and a potential avenue for cancer treatment.
Zhao C; Wang M; Cheng A; Yang Q; Wu Y; Zhu D; Chen S; Liu M; Zhao X; Jia R; Sun K; Chen X
Oncotarget; 2018 Jul; 9(55):30704-30719. PubMed ID: 30093980
[TBL] [Abstract][Full Text] [Related]
87. System-based strategies for p53 recovery.
Azam MR; Fazal S; Ullah M; Bhatti AI
IET Syst Biol; 2018 Jun; 12(3):101-107. PubMed ID: 29745903
[TBL] [Abstract][Full Text] [Related]
88. Understanding non-linear effects from Hill-type dynamics with application to decoding of p53 signaling.
Shi X; Reimers JR
Sci Rep; 2018 Feb; 8(1):2147. PubMed ID: 29391550
[TBL] [Abstract][Full Text] [Related]
89. Revealing determinants of two-phase dynamics of P53 network under gamma irradiation based on a reduced 2D relaxation oscillator model.
Demirkıran G; Kalaycı Demir G; Güzeliş C
IET Syst Biol; 2018 Feb; 12(1):26-38. PubMed ID: 29337287
[TBL] [Abstract][Full Text] [Related]
90. Stress and the nonsense-mediated RNA decay pathway.
Goetz AE; Wilkinson M
Cell Mol Life Sci; 2017 Oct; 74(19):3509-3531. PubMed ID: 28503708
[TBL] [Abstract][Full Text] [Related]
91. Significance of Wild-Type p53 Signaling in Suppressing Apoptosis in Response to Chemical Genotoxic Agents: Impact on Chemotherapy Outcome.
Mirzayans R; Andrais B; Kumar P; Murray D
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452953
[TBL] [Abstract][Full Text] [Related]
92. Modeling amplified p53 responses under DNA-PK inhibition in DNA damage response.
Sun T; Li X; Shen P
Oncotarget; 2017 Mar; 8(10):17105-17114. PubMed ID: 28177883
[TBL] [Abstract][Full Text] [Related]
93. Mathematical Modeling of p53 Pathways.
Kim E; Kim JY; Lee JY
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635420
[TBL] [Abstract][Full Text] [Related]
94. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
95. Mathematical modeling of cell cycle regulation in response to DNA damage: exploring mechanisms of cell-fate determination.
Iwamoto K; Hamada H; Eguchi Y; Okamoto M
Biosystems; 2011 Mar; 103(3):384-91. PubMed ID: 21095219
[TBL] [Abstract][Full Text] [Related]
96. Mathematical model identifies effective P53 accumulation with target gene binding affinity in DNA damage response for cell fate decision.
Sun T; Mu D; Cui J
Cell Cycle; 2018; 17(24):2716-2730. PubMed ID: 30488759
[TBL] [Abstract][Full Text] [Related]
97. The p53 protein and its molecular network: modelling a missing link between DNA damage and cell fate.
Eliaš J; Dimitrio L; Clairambault J; Natalini R
Biochim Biophys Acta; 2014 Jan; 1844(1 Pt B):232-47. PubMed ID: 24113167
[TBL] [Abstract][Full Text] [Related]
98. Dynamics of P53 in response to DNA damage: Mathematical modeling and perspective.
Sun T; Cui J
Prog Biophys Mol Biol; 2015 Nov; 119(2):175-82. PubMed ID: 26278643
[TBL] [Abstract][Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
